Cancer Letters
Volume 226, Issue 1 , Pages 55-63 , 8 August 2005

Potential of faecal RNA in diagnosing colorectal cancer

  • Shung-Haur Yang

      Affiliations

    • Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, No 201, Sec 2, Shih-Pai Rd 11217, Taipei, Taiwan, ROC
    • Institude of Clinical Medicine, National Yang-Ming University, No 155, Sec 2, Li-Nong St 11221,Taipei, Taiwan, ROC
    • Both authors contributed equally to this work.
    • ,
  • Chih-Cheng Chien

      Affiliations

    • Neuroscience Laboratory, Cathay Medical Research Institute, Cathay General Hospital, No 32, Ln 160, Jian-Cheng Rd, Hsi-Chih, Taipei, 22141, Taiwan, ROC
    • School of Medicine, Fu Jen Catholic University, No 510 Chung-Cheng Rd, Hsinchuang, Taipei, 24205, Taiwan, ROC
    • Both authors contributed equally to this work.
    • ,
  • Chan-Wei Chen

      Affiliations

    • Molecular Genetics and Biochemistry Laboratory, Cathay Medical Research Institute, Cathay General Hospital, No 32, Ln 160, Jian-Cheng Rd, Hsi-Chih, Taipei, 22141, Taiwan, ROC
    • ,
  • Shih-Yun Li

      Affiliations

    • Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, No 201, Sec 2, Shih-Pai Rd 11217, Taipei, Taiwan, ROC
    • ,
  • Chi-Jung Huang

      Affiliations

    • Molecular Genetics and Biochemistry Laboratory, Cathay Medical Research Institute, Cathay General Hospital, No 32, Ln 160, Jian-Cheng Rd, Hsi-Chih, Taipei, 22141, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +886 2 26907965; fax: +886 2 26907963.

Received 12 October 2004 ,Revised 1 November 2004 ,Accepted 2 November 2004.

References 

  1. Ahlquist DA, Harrington JJ, Burgart LJ, Roche PC. Morphometric analysis of the ‘mucocellular layer’ overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum. Pathol. 2000;31:51–57
  2. Ahlquist DA, Shuber AP. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin. Chim. Acta. 2002;315:157–168
  3. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. 2000;119:1219–1227
  4. Albaugh GP, Iyengar V, Lohani A, Malayeri M, Bala S, Nair PP. Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers. Int. J. Cancer. 1992;52:347–350
  5. Alexander RJ, Raicht RF. Purification of total RNA from human stool samples. Dig. Dis. Sci. 1998;43:2652–2658
  6. Baricault L, de Nechaud B, Sapin C, Codogno P, Denoulet P, Trugnan G. The network organization and the phosphorylation of cytokeratins are concomitantly modified by forskolin in the enterocyte-like differentiated Caco-2 cell line. J. Cell Sci. 1994;107:2909–2918
  7. Berois N, Varangot M, Aizen B, Estrugo R, Zarantonelli L, Fernandez P, et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur. J. Cancer. 2000;36:717–723
  8. Davidson LA, Aymond CM, Jiang YH, Turner ND, Lupton JR, Chapkin RS. Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer. Carcinogenesis. 1998;19:253–257
  9. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. 2001;7:3289–3297
  10. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J. Natl. Cancer Inst. 2001;93:858–865
  11. Galan M, Vinolas N, Colomer D, Soler G, Munoz M, Longaron R, et al. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation. Anticancer Res. 2002;22:2877–2884
  12. Grimm DH, Cai Y, Chauvet V, Rajendran V, Zeltner R, Geng L, et al. Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J. Biol. Chem. 2003;278:36786–36793
  13. Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, Meagher A, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002;122:1376–1387
  14. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J. Surg. 1995;19:184–190
  15. Ismail MS, Wynendaele W, Aerts JL, Paridaens R, Gaafar R, Shakankiry N, et al. Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR. Clin. Cancer Res. 2004;10:196–201
  16. Iyengar V, Albaugh GP, Lohani A, Nair PP. Human stools as a source of viable colonic epithelial cells. Fed. Am. Soc. Exp. Biol. J. 1991;5:2856–2859
  17. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004 CA. Cancer J. Clin. 2004;54:8–29
  18. Kawada M, Mizuno M, Nasu J, Uesu T, Okazaki H, Okada H, et al. Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor. J. Lab. Clin. Med. 2003;142:306–312
  19. Loktionov A, O'Neill IK, Silvester KR, Cummings JH, Middleton SJ, Miller R. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin. Cancer Res. 1998;4:337–342
  20. Majima T, Ichikura T, Takayama E, Chochi K, Mochizuki H. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer. Jpn. J. Clin. Oncol. 2000;30:499–503
  21. Marchena J, Acosta MA, Garcia-Anguiano F, Simpson H, Cruz F. Use of the preoperative levels of CEA in patients with colorectal cancer. Hepatogastroenterology. 2003;50:1017–1020
  22. Nakagawa M, Mizuno M, Kawada M, Uesu T, Nasu J, Takeuchi K, et al. Polymorphic expression of decay-accelerating factor in human colorectal cancer. J. Gastroenterol. Hepatol. 2001;16:184–189
  23. Potten CS, Allen TD. Ultrastructure of cell loss in intestinal mucosa. J. Ultrastruct. Res. 1977;60:272–277
  24. Raskin HF, Pleticka S. Exfoliative cytology of the colon. Fifteen years of lost opportunity, Cancer. 1971;28:127–130
  25. Rengucci C, Maiolo P, Saragoni L, Zoli W, Amadori D, Calistri D. Multiple detection of genetic alterations in tumors and stool. Clin. Cancer. Res. 2001;7:590–593
  26. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256:102–105
  27. Silva JM, Rodriguez R, Garcia JM, Munoz C, Silva J, Dominguez G, et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut. 2002;50:530–534
  28. Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut. 1995;36:81–86
  29. Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, et al. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Anticancer Res. 2003;23:1883–1890
  30. Strater J, Wedding U, Barth TF, Koretz K, Elsing C, Moller P. Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells. Gastroenterology. 1996;110:1776–1784
  31. Tokunaga E, Ishida M, Kimura Y, Maehara Y. Correlation with bone metastasis and high expression of CK 19 mRNA measured by quantitative RT-PCR in the bone marrow of breast cancer patients. Breast J. 2003;9:440–442
  32. Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003;94:851–857
  33. Whittier CA, Horne W, Slenning B, Loomis M, Stoskopf MK. Comparison of storage methods for reverse-transcriptase PCR amplification of rotavirus RNA from gorilla (Gorilla g. gorilla) fecal samples. J. Virol. Methods. 2004;116:11–17
  34. Wong IH, Yeo W, Chan AT, Johnson PJ. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett. 2001;162:65–73
  35. Yamao T, Matsumura Y, Shimada Y, Moriya Y, Sugihara K, Akasu T, et al. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology. 1998;114:1196–1205
  36. Yuan CC, Wang PH, Ng HT, Li YF, Huang TS, Chen CY, et al. Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation. Gynecol. Oncol. 2002;85:148–153

PII: S0304-3835(04)00863-8

doi: 10.1016/j.canlet.2004.11.005

Cancer Letters
Volume 226, Issue 1 , Pages 55-63 , 8 August 2005

Article Tools

* Image Usage & Resolution